Otonomy, Inc.
Records under this name other than the patents Otonomy, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,751,281 | Auris Formulations for Treating Otic Diseases and Conditions now held by Dompé Farmaceutici S.P.A. In force · High confidence | In force | High confidence | |
| US 11,123,285 | Auris Formulations for Treating Otic Diseases and Conditions now held by Dompé Farmaceutici S.P.A. In force · High confidence | In force | High confidence | |
| US 11,969,501 | Auris Formulations for Treating Otic Diseases and Conditions now held by Dompé Farmaceutici S.P.A. In force · High confidence | In force | High confidence | |
| US 11,918,653 | Triglyceride Otic Formulations and Uses Thereof now held by Dompé Farmaceutici S.P.A. In force · High confidence | In force | High confidence | |
| US 10,092,580 | Controlled-Release Otic Structure Modulating and Innate Immune System Modulating Compositions and Methods for the Treatment of Otic Disorders now held by The Regents of the University of California Lapsed on the fee record Ended Oct 9, 2026 · Low confidence | Lapsed on the fee record | Ended Oct 9, 2026 | Low confidence |
| US 8,852,626 | Controlled-Release CNS Modulating Compositions and Methods for the Treatment of Otic Disorders now held by The Regents of the University of California Lapsed on the fee record Ended Oct 7, 2026 · High confidence | Lapsed on the fee record | Ended Oct 7, 2026 | High confidence |
| US 8,784,870 | Controlled Release Compositions for Modulating Free-Radical Induced Damage and Methods of Use Thereof now held by The Regents of the University of California Lapsed on the fee record Ended Jul 22, 2026 · High confidence | Lapsed on the fee record | Ended Jul 22, 2026 | High confidence |
| US 11,369,566 | Controlled Release Antimicrobial Compositions and Methods for the Treatment of Otic Disorders now held by Alk-Abelló, Inc. Lapsed on the fee record Ended Jun 28, 2026 · Medium confidence | Lapsed on the fee record | Ended Jun 28, 2026 | Medium confidence |
| US 8,680,082 | Controlled Release Corticosteroid Compositions and Methods for the Treatment of Otic Disorders Lapsed on the fee record Ended Mar 25, 2026 · High confidence | Lapsed on the fee record | Ended Mar 25, 2026 | High confidence |
| US 11,246,863 | Ciprofloxacin Otic Composition and Kits and Method for Using Same now held by Alk-Abelló, Inc. Lapsed on the fee record Ended Feb 15, 2026 · High confidence | Lapsed on the fee record | Ended Feb 15, 2026 | High confidence |